Related Experiment Video
Updated: Jul 18, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic
Jonathan T Ting1, Brooke G Kelley, Talley J Lambert
1Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Abstract:
Overexpression of the amyloid precursor protein (APP) in hippocampal neurons leads to elevated beta-amyloid peptide (Abeta) production and consequent depression of excitatory transmission. The precise mechanisms underlying APP-induced synaptic depression are poorly understood. Uncovering these mechanisms could provide insight into how neuronal function is compromised before cell death during the early stages of Alzheimer's disease. Here we verify that APP up-regulation leads to depression of transmission in cultured hippocampal autapses; and we perform whole-cell recording, FM imaging, and immunocytochemistry to identify the specific mechanisms accounting for this depression. We find that APP overexpression leads to postsynaptic silencing through a selective reduction of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor-mediated currents. This effect is likely mediated by Abeta because expression of mutant APP incapable of producing Abeta did not depress transmission. In addition, although we eliminate presynaptic silencing as a mechanism underlying APP-mediated inhibition of transmission, we did observe an Abeta-induced presynaptic deficit in vesicle recycling with sustained stimulation. These findings demonstrate that APP elevation disrupts both presynaptic and postsynaptic compartments.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Drugs Affecting Neurotransmitter Synthesis
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Neurochemical Transmission: Sites of Drug Action
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
